Prognostic value of microRNA 502 binding site snp in the 3'-untranslated region of the SET8 gene in patients with non-Hodgkin's lymphoma

Tumori

Volumn 100, Issue 5, 2014, Pages 553-558

  Diao, Lanping ^a   Su, Huiling ^a   Wei, Guangchuan ^a   Li, Tao ^a   Gao, Yuhuan ^a   Zhao, Guimin ^a   Guo, Zhanjun ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

MicroRNA; NHL; SET8; SNP; Survival

Indexed keywords

MICRORNA; MICRORNA 502; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; HISTONE LYSINE METHYLTRANSFERASE; MIRN502 MICRORNA, HUMAN; SETD8 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADOLESCENT; ADULT; AGED; ARTICLE; BINDING SITE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; FEMALE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICRORNA BINDING SITE; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; SET8 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE; SURVIVAL TIME; T CELL LYMPHOMA; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RNA INTERFERENCE; VERY ELDERLY; YOUNG ADULT;

3' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BINDING SITES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOMA, NON-HODGKIN; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RNA INTERFERENCE; YOUNG ADULT;

EID: 84916937398     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/1660.18180     Document Type: Article

References (32)

1. Fang J, Feng Q, Ketel CS, Wang H, Cao R, Xia L, Erdjument-Bromage H, Tempst P, Simon JA, Zhang Y: Purification and functional characterization of SET8, a nucleosomal histone H4-lysine 20-specific methyltransferase. Curr Biol, 12: 1086-1099, 2002.
2. Zhang Y, Reinberg D: Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev, 15: 2343-2360, 2001.
3. Schotta G, Lachner M, Sarma K, Ebert A, Sengupta R, Reuter G, Reinberg D, Jenuwein T: A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev, 18: 1251-1262, 2004.
4. Sanders SL, Portoso M, Mata J, Bähler J, Allshire RC, Kouzarides T: Methylation of histone H4 lysine 20 controls recruitment of Crb2 to sites of DNA damage. Cell, 119: 603-614, 2004.
5. Jones PA, Baylin SB: The epigenomics of cancer. Cell, 128: 683-692, 2007.
6. Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G, Bonaldi T, Haydon C, Ropero S, Petrie K, Iyer NG, Pérez-Rosado A, Calvo E, Lopez JA, Cano A, Calasanz MJ, Colomer D, Piris MA, Ahn N, Imhof A, Caldas C, Jenuwein T, Esteller M: Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4is a common hallmark of human cancer. Nat Genet, 37: 391-400, 2005.
7. Yin Y, Liu C, Tsai SN, Zhou B, Ngai SM, Zhu G: SET8 recognizes the sequence RHRK20VLRDN within the N terminus of histone H4 and mono-methylates lysine 20. J Biol Chem, 280: 30025-30031, 2005.
8. Couture JF, Collazo E, Brunzelle JS, Trievel RC: Structural and functional analysis of SET8, a histone H4Lys-20 methyltransferase. Genes Dev, 19: 1455-1465, 2005.
9. Huen MS, Sy SM, van Deursen JM, Chen J: Direct interaction between SET8 and proliferating cell nuclear antigen couples H4-20 methylation with DNA replication. J Biol Chem, 283: 11073-11077, 2008.
10. Jorgensen S, Elvers I, Trelle MB, Menzel T, Eskildsen M, Jensen ON, Helleday T, Helin K, Sorensen CS: The histone methyltransferase SET8 is required for S-phase progression. J Cell Biol, 179: 1337-1345, 2007.
11. Yin Y, Yu VC, Zhu G, Chang DC: SET8 plays a role in controlling G1/S transition by blocking lysine acetylation in histone through binding to H4 N-terminal tail. Cell Cycle, 7: 1423-1432, 2008.
12. Houston SI, McManus KJ, Adams MM, Sims JK, Carpenter PB, Hendzel MJ, Rice JC: Catalytic function of the PR-Set7 histone H4lysine 20 monomethyltransferase is essential for mitotic entry and genomic stability. J Biol Chem, 283: 19478-19488, 2008.
13. Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell, 136: 215-233, 2009.
14. Ambros V: The functions of animal microRNAs. Nature, 431: 350-355, 2004.
15. Calin GA, Croce CM: MicroRNA-cancer connection: the beginning of a new tale. Cancer Res, 66: 7390-7394, 2006.
16. Ventura A, Jacks T:MicroRNAs and cancer: short RNAs go a long way. Cell, 136: 586-591, 2009.
17. Landi D, Gemignani F, Naccarati A, Pardini B, Vodicka P, Vodickova L, Novotny J, Försti A, Hemminki K, Canzian F, Landi S: Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis, 29: 579-584, 2008.
18. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW:WHO classification of tumours of haematopoietic and lymphoid tissues, p 439. International Agency for Research on Cancer, Lyon, 2008.
19. Song F, Zheng H, Liu B, Wei S, Dai H, Zhang L, Calin GA, Hao X, Wei Q, Zhang W, Chen K: An miR-502-binding site single-nucleotide polymorphism in the 3-untranslated region of the SET8 gene is associated with early age of breast cancer onset. Clin Cancer Res, 15: 6292-6300, 2009.
20. Guo Z, Wu C, Wang X, Wang C, Zhang R, Shan B: A polymorphism at the miR-502 binding site in the 3'-untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcome. Int J Cancer, 131: 1318-1322, 2012.
21. Han X, Kilfoy B, Zheng T, Holford TR, Zhu C, Zhu Y, Zhang Y: Lymphoma survival patterns by WHO subtype in the United States, 1973-2003. Cancer Causes Control, 19: 841-858, 2008.
22. Wang SS, Maurer MJ, Morton LM, Habermann TM, Davis S, Cozen W, Lynch CF, Severson RK, Rothman N, Chanock SJ, Hartge P, Cerhan JR: Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma. Leukemia, 23: 596-602, 2009.
23. Wang SS, Purdue MP, Cerhan JR, Zheng T, Menashe I, Armstrong BK, Lan Q, Hartge P, Kricker A, Zhang Y, Morton LM, Vajdic CM, Holford TR, Severson RK, Grulich A, Leaderer BP, Davis S, Cozen W, Yeager M, Chanock SJ, Chatterjee N, Rothman N: Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLoS One, 4: e5360, 2009.
24. Diao LP, Ma H, Wei GC, Li T, Liu HS, Liu LH, Wu LL, Zhao GM, Gao YH:Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin's lymphoma. Int J Cancer, 131: 1095-1103, 2012.
25. Ding C, Li R, Peng J, Li S, Guo Z: A polymorphism at the miR-502 binding site in the 3' untranslated region of the SET8 gene is associated with the outcome of small-cell lung cancer. Exp Ther Med, 3: 689-692, 2012.
26. Shi X, Kachirskaia I, Yamaguchi H, West LE, Wen H, Wang EW, Dutta S, Appella E, Gozani O: Modulation of p53 function by SET8-mediated methylation at lysine 382. Mol Cell 27: 636-646, 2007.
27. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, Liu S, Alder H, Costinean S, Fernandez-Cymering C, Volinia S, Guler G, Morrison CD, Chan KK, Marcucci G, Calin GA, Huebner K, Croce CM: MicroRNA 29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA, 104: 15805-15810, 2007.
28. Tuddenham L, Wheeler G, Ntounia-Fousara S, Waters J, Hajihosseini MK, Clark I, Dalmay T: The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett, 580: 4214-4217, 2006.
29. Brendle A, Lei H, Brandt A, Johansson R, Enquist K, Henriksson R, Hemminki K, Lenner P, Försti A: Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker. Carcinogenesis, 29: 1394-1399, 2008.
30. Gao Y, He Y, Ding J, Wu K, Hu B, Liu Y, Wu Y, Guo B, Shen Y, Landi D, Landi S, Zhou Y, Liu H: An insertion/deletion polymorphism at miRNA-122-binding site in the inter-leukin-1a 3'untranslated region confers risk for hepatocellular carcinoma. Carcinogenesis, 30: 2064-2069, 2009.
31. Yu Z, Li Z, Jolicoeur N, Zhang L, Fortin Y, Wang E, Wu M, Shen SH: Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic Acids Res, 35: 4535-4541, 2007.
32. Diao LP, Yu XM, Gao YH, Li Y, Liu HS, Liu LH, Zhou RM, Wang N, Wu LL, Wang SJ: Association of VEGF genetic polymorphisms with the clinical characteristics of non-Hodgkin's lymphoma. J Cancer Res Clin Oncol, 135: 1473-1481, 2009.